This clip from @profgalloway.com resonates with something I recently wrote about rejection in academic medicine. substack.com/@trialisttri...

Circling back to this a year later…
@ebtapper.bsky.social I would argue that the data itself is good but it MUST be handled at the IPD level by statistical experts. I think >95% of studies using aggregate data and the TriNetX UI analytics are not believable. www.cghjournal.org/article/S154...

We Regret to Inform You... Lessons from the rejection pile

open.substack.com/pub/trialist...

The Opportunity Cost of Status Quo Science Why innovation in trial design matters for patients, clinicians, and the future of medicine

open.substack.com/pub/trialist...

Content being content: Tuning out the unrest of others TTT goes a bit sentimental about career mobility, institutional fit, and the quiet power of support

open.substack.com/pub/trialist...

Time to RESUME: Rekindling Trialist Tribulations Charting a new course for RESUME after PCORI—and amid the current political climate

substack.com/@trialisttri...

“Institutions don’t love you back” is a favorite of mine & one highlighted by Scott Galloway. I don’t have loyalty to my institution because it is an inanimate object. It can’t love me back. I have loyalty to people.

Researchers, trialists, and all, I've started a Substack publication called The Trialist Tribulations. The first edition drops tonight. I'd be grateful if you gave it a read. Please consider subscribing if you don't hate it. 🤞
#MedSky #AcademicSky #GISky open.substack.com/pub/trialist...

Won’t be easy to tell a coffee lover they have a 50% chance of being randomized to no coffee for a number of years! That trial is gonna fail to meet its enrollment goal.

Coming soon: The Trialist Tribulations The Trialist Tribulations is a new publication consisting of "weekly musings from the world of academic medicine."

open.substack.com/pub/trialist...